CAS Star
VC Fund
Xian, China
CAS Star is a VC fund in Xian focused on Manufacturing and Artificial Intelligence. CAS Star engages in high-tech industry incubation and venture capital investment. It builds a scientific and technological entrepreneurial ecosystem that includes research institutions, angel funds, incubators, and entrepreneurship training. This system provides structured support for technology entrepreneurs.
- Total investments:
- 280
- Last investment:
- Lead investor:
- 41%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries CAS Star invests in
Stages CAS Star invests in
Countries CAS Star invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Hao Li
|
|||
|
Lei Mi
|
|||
2 more contacts available
Investment Focus
Industry
- Manufacturing 59 (21%)
- Artificial Intelligence 26 (9%)
- Electronics 24 (9%)
- Semiconductor 22 (8%)
- Information Technology 21 (8%)
Stage
- Angel 75 (27%)
- Series A 60 (21%)
- Seed 52 (19%)
- Series B 21 (8%)
- Funding Round 6 (2%)
Country
- China 182 (65%)
- United States 4 (1%)
- Switzerland 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hao Li
Founding Partner & Co-Chief Executive Officer
|
Founding Partner & Co-Chief Executive Officer | Total investments: 0 | Find email | |
|
Lei Mi
Founding Partner & Co-Chief Executive Officer
|
Founding Partner & Co-Chief Executive Officer | Total investments: 2 | Find email | |
|
Mi Lei
Founding partner
|
Founding partner | Total investments: 12 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
ClonOrgan has developed a technology to humanize pig cells that will grow into human-compatible organs.The business specializes in xenotransplantation and has a one-stop R&D platform that includes raising gene-edited pigs, preclinical testing, and breeding. It is dedicated to addressing the critical shortage of clinical organ transplantationand creating the organ factory of the future.ClonOrgas was established in 2005 in Chengdu, Sichuan. | Series A / Aug 07, 2026 | |
|
|
Zheyuan Technology is an AI pharmaceutical R&D solution provider. | $29.6M / Series A / Aug 05, 2026 | |
|
Active Technology
|
Active Technology is a pioneering deep tech startup specialized in developing invasive brain computer interface (BCI) technology. The company integrates flexible electrodes, dedicated chips, and advanced decoding algorithms to target motor, visual, and emotional neural pathways. | $48.9M / Angel / Aug 03, 2026 | |
|
MatraVolt
|
MatraVolt is a rising star in the technological market, concentrating on innovative energy materials technology. | Angel / Aug 03, 2026 | |
|
|
Wuke Superconducting is a developer of high-temperature superconducting tapes, mainly engaged in the research, development, preparation and industrialization of high-temperature superconducting tapes. It has built a high-temperature superconducting full-chain industrialization platform that integrates superconducting target development, coreequipment development, high-performance tape preparation and extreme performance characterization of wire and tape materials. | Angel / Jul 31, 2026 | |
|
Valhalla Technology
|
Valhalla Tech develops full-modal molecular world models to engineer novel proteins, nucleic acids, and small molecules from scratch. The platform integrates generative artificial intelligence with automated high-throughput experimental testing to accelerate molecular and biomolecular design. Its core technology operates across multiple molecularmodalities to simulate complex physical and chemical interactions. The enterprise applies these computational frameworks to solve challenges in drug discovery, therapeutics, and broader scientific research. | $7.4M / Seed / Jul 28, 2026 | |
|
|
Beijing Xingyuan Zongheng Network Technology is an aerospace and satellite internet enterprise. The company focuses on high-tech satellite system development, constellation networking, and commercial operations. | $14.8M / Angel / Jul 17, 2026 | |
|
Strong Fields
|
Strong Field is a new materials enterprise focusing on the research and development of engineering application technology of high-temperature superconducting magnets and the sales of related experimental instruments . | Angel / Jul 17, 2026 | |
|
|
Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights. | $14.8M / Seed / Jul 16, 2026 | |
|
|
ENN develops technologies and conducts research focused on sustainable energy solutions. The company works on proton-boron fusion, compact fusion systems, and other advanced energy generation approaches. Its services include designing experimental fusion reactors, modeling plasma behavior, and developing computational tools for energy simulations.ENN also engages in partnerships with universities, research institutes, and industry organizations to advance innovation in energy science. The company supports efforts to create scalable, low-carbon energy technologies and to explore applications in electricity generation and related scientific research. | Seed / Jul 10, 2026 | |
| See all 280 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does CAS Star invest in?
CAS Star invests primarily in Manufacturing, Artificial Intelligence and Electronics startups, most often at Angel and Series A stage. Most of the 280 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact CAS Star?
Public channels for CAS Star include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CAS Star?
The team at CAS Star includes Hao Li (Founding Partner & Co-Chief Executive Officer), Lei Mi (Founding Partner & Co-Chief Executive Officer) and Mi Lei (Founding partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!